Prognostic factors in adolescents and young adults (AYA) with high risk soft tissue sarcoma (STS) treated by adjuvant chemotherapy: A study based on pooled European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62771 and 62931

European Journal of Cancer

Volumn 49, Issue 2, 2013, Pages 449-456

  Kasper, Bernd ^a   Ouali, Monia ^b   Van Glabbeke, Martine ^b   Blay, Jean Yves ^c   Bramwell, Vivien H C ^d   Woll, Penella J ^e   Hohenberger, Peter ^a   Schöffski, Patrick ^f  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b EORTC DATA CENTER   (Belgium)

^c CENTRE LÉON BÉRARD   (France)

^d TOM BAKER CANCER CENTRE   (Canada)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

^f UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Adolescents; EORTC; Prognostic factors; Soft tissue sarcoma; Young adults

Indexed keywords

ANTINEOPLASTIC AGENT;

ADOLESCENT; ADULT; ANGIOSARCOMA; ARTICLE; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER PROGNOSIS; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; FEMALE; FIBROSARCOMA; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LEIOMYOSARCOMA; LIMB TUMOR; LIPOSARCOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT FIBROUS HISTIOCYTOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; RADICAL RESECTION; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; RHABDOMYOSARCOMA; SOFT TISSUE SARCOMA; SYNOVIAL SARCOMA; TUMOR LOCALIZATION; TUMOR VOLUME; UNDIFFERENTIATED PLEOMORPHIC SARCOMA;

ADOLESCENT; ADULT; AGE FACTORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SARCOMA; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84872104838     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2012.08.007     Document Type: Article

References (19)

1. C.E. Herzog Overview of sarcomas in the adolescent and young adult population J Pediatr Hematol Oncol 27 2005 215 218
2. K.H. Albritton Sarcomas in adolescents and young adults Hematol Oncol Clin North Am 19 2005 527 546
3. J.G. Gurney, A.R. Swensen, and M. Bulterys Malignant bone tumors L.A.G. Reis, M.A. Smith, J.G. Gurney, Cancer incidence and survival among children and adolescents: United States SEER program 1975-1995 1999 National Cancer Institute Program. NIH Pub. No. 99-4649 Bethesda, MD 99 110
4. J.G. Gurney, J.L. Young, and S.D. Roffers Soft tissue sarcomas L.A.G. Reis, M.A. Smith, J.G. Gurney, Cancer incidence and survival among children and adolescents: United States SEER program 1975-1995 1999 National Cancer Institute Program. NIH Pub. No. 99-4649 Bethesda, MD 111 123
5. H.C.F. Bauer, T.A. Alvegard, and O. Berlin The Scandinavian Sarcoma Group Register Acta Orthop Scand 70 1999 41 44
6. W. Crist, E.A. Gehan, and M. Beltangady The Third Intergroup Rhabdomyosarcoma Study J Clin Oncol 13 1995 610 630
7. K. Winkler, G. Beron, and G. Belling Neoadjuvant chemotherapy of osteosarcomas: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response J Clin Oncol 6 1988 329 337
8. M. Paulussen, S. Ahrens, and J. Dunst Localized Ewing tumor of bone: final results of the Cooperative Ewing's Sarcoma Study CESS 86 J Clin Oncol 19 2001 1818 1839
9. V. Bramwell, J. Rouesse, and W. Steward Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma-reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group J Clin Oncol 12 1994 1137 1149
10. Woll PJ, Reichardt P, Le Cesne A, et al. Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial. Lancet Oncol, 2012, in press.
11. F.G. Barr, J. Chatten, and C.M. D'Cruz Molecular assays for chromosomal translocations in the diagnosis of pediatric soft tissue sarcomas JAMA 273 1995 553 557
12. A. Kawai, J. Woodruff, J.H. Healey, M.F. Brennan, C.R. Antonescu, and M. Ladanyi SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma N Engl J Med 338 1998 153 160
13. I. Panagopoulos, M. Hoglund, F. Mertens, N. Mandahl, F. Mitelman, and P. Aman Fusion of the EWS and CHOP genes in myxoid liposarcomas Oncogene 12 1996 489 494
14. O. Delattre, J. Zucman, and T. Melot The Ewing family of tumors: a subgroup of small-round-cell tumors defined by specific chimeric transcripts N Engl J Med 331 1994 294 299
15. A. Ferrari, R. Miceli, and C. Meazza Soft tissue sarcomas of childhood and adolescence. the prognostic role of tumor size in relation to patient body size J Clin Oncol 27 2009 371 376
16. A. Le Cesne, M. Van Glabbeke, and P.J. Woll The end of adjuvant chemotherapy (adCT) era with doxorubicin-based regimen in resected high-grade soft tissue sarcoma (STS): pooled analysis of the two STBSG-EORTC phase III clinical trials J Clin Oncol 26 2008 Abstract 10525
17. W.A. Bleyer The adolescent gap in cancer treatment J Registry Manag 23 1996 114 115
18. W.A. Bleyer, H. Tejeda, and S.M. Murphy National cancer clinical trials: children have equal access; adolescents do not J Adolesc Health 21 1997 366 373
19. A. Bleyer, M. Montello, and T. Budd Young adults with sarcoma: lack of clinical trial participation and lack of survival prolongation Proc Am Soc Clin Oncol 22 2003 816 (Abstract 3280)